DOPATREE
Preview
Open in TheBrain
DOPATREE
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
ONCOLOGY CONDITIONS-ALL (CANCERS, TUMORS, NODULES, MALIGNANCY)
ONCOLOGY CONDITIONS / TYPES
HEREDITARY CANCERS-ALL (FAMILY, FAMILIES, INHERITED CANCERS, INHERITED TUMORS, GENETIC TUMORS, TUMOURS, GENETIC CANCERS, SYNDROMES)
HEREDITARY CANCERS / OVERVIEW
Parents
HEREDITARY CANCERS-ALL (FAMILY, FAMILIES, INHERITED CANCERS, INHERITED TUMORS, GENETIC TUMORS, TUMOURS, GENETIC CANCERS, SYNDROMES)
Children
US NIH-NCI. CANCER GENETICS OVERVIEW (PDQ®). ACCESSED : APR 11, 2022.
US NIH-NCI. CANCER GENETICS RISK ASSESSMENT AND COUNSELING (PDQ®). ACCESSED : APR 11, 2022.